Please use this identifier to cite or link to this item:
http://hdl.handle.net/11375/28412
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.advisor | Bryant-Lukosius, Denise | - |
dc.contributor.author | Huber, Tracey | - |
dc.date.accessioned | 2023-03-30T14:45:34Z | - |
dc.date.available | 2023-03-30T14:45:34Z | - |
dc.date.issued | 2023-05-24 | - |
dc.identifier.uri | http://hdl.handle.net/11375/28412 | - |
dc.description.abstract | Background: Treatment for advanced gastrointestinal (GI) cancer frequently requires continuous administration of 5-Fluorouracil (5-FU) over 46-hours through an ambulatory infusor. While convenient, evidence suggests that infusors may impact day-to-day activities and health-related quality of life (HRQL). There is limited research on the impact of this technology on patients' health, or if current practices meet their health needs. This study aimed to explore patient experiences receiving 5-FU through an ambulatory infusor at home for GI cancers. Methods: A qualitative descriptive design was employed. Participants were patients diagnosed with a GI cancer who had received 5-FU through an ambulatory infusor for 46 hours within the last twelve months at a cancer centre in Southwestern Ontario. Semi-structured interviews were conducted by telephone, transcribed verbatim, and analyzed using content analysis methods to code data and identify relevant patterns and themes. Results: Ten patients with four types of GI cancers participated in the study. Their experience with ambulatory infusors ranged from 8 to 54 treatment cycles. Common themes included the psychosocial impact of having an infusor, the intense work of patient self-management, and supporting patients in self-management. Conclusions: Results indicate that use of an infusor may have a more negative effect on patients' mental health than previously understood. Psychosocial assessment and support should be routinely utilized, and significant efforts should be made to prepare patients for living with an infusor. Streamlining services and reducing the number of cancer care-related appointments would also lessen the burden currently placed on patients. | en_US |
dc.language.iso | en | en_US |
dc.subject | Infusor, 5-Fluorouracil, Patient Experience, Gastrointestinal Cancer, Nursing Role | en_US |
dc.title | Ambulatory 5-Fluorouracil Infusors: Experiences of Patients Diagnosed with Gastrointestinal Cancer | en_US |
dc.type | Thesis | en_US |
dc.contributor.department | Nursing | en_US |
dc.description.degreetype | Thesis | en_US |
dc.description.degree | Master of Science in Nursing (MSN) | en_US |
dc.description.layabstract | Some patients diagnosed with a cancer in the gastrointestinal (GI) system receive a medication called 5-Fluorouracil (5-FU) through a small infusion device that they take home. This device slowly infuses the medication over 46-hours. While there are many conveniences in receiving treatment at home, the infusor can interfere with daily activities and patients must know how to monitor the device. This study aimed to explore patient experiences receiving 5-FU through an ambulatory infusor at home for the treatment of GI cancers. Results showed that patients receiving 5-FU at home through an infusor experience psychosocial distress, find it difficult to keep up with the many cancer-related appointments, and would benefit from improved education regarding psychosocial supports and venous access devices. It is important that patients are prepared for the challenges that this infusion device may present to their daily life and well-being. | en_US |
Appears in Collections: | Open Access Dissertations and Theses |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Huber_Tracey_M_FinalSubmission2023March_MasterofScienceinNursing.pdf | 1.26 MB | Adobe PDF | View/Open |
Items in MacSphere are protected by copyright, with all rights reserved, unless otherwise indicated.